BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:California Life Sciences
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260603T110000
DTEND;TZID=America/New_York:20260603T130000
DTSTAMP:20260603T160737
CREATED:20260521T164804Z
LAST-MODIFIED:20260521T164804Z
UID:10001091-1780484400-1780491600@www.califesciences.org
SUMMARY:Endpoints at #ASCO26
DESCRIPTION:ASCO is where oncology pipelines get stress-tested in front of the entire world. Readouts can make or break big pharma strategies and reshape treatment paradigms overnight. Join Endpoints News and leading oncology researchers as we break down the science and data worth a second look. We’re examining new readouts\, unpacking the most anticipated trials on deck and discussing the biggest themes in cancer research. \nAgenda\n11:00 AM – 11:25 AM ET: In conversation with Jeff Legos\nWe’ll sit down with Pfizer’s Chief Oncology Officer for an update after his first year on the job\, and how he’s thinking through the pharma’s cancer pipeline. \n11:30 AM – 11:55 AM ET: Catching KRAS\nFor decades\, KRAS was an obvious target for cancer treatments. And for decades\, it seemed like an undruggable target. But that started to change with the first approved KRAS therapies. Research took off\, and now\, new data on pancreatic cancer suggest a potential breakthrough. Join pioneers in the space for a conversation on recent progress and where the work goes next. \n12:00 PM – 12:30 PM ET: Delivering excellence\, close to home\nCommunity oncology is the backbone of cancer care in the U.S.\, treating the majority of patients and ensuring care is delivered close to home in communities across the country. This panel will explore how community oncologists are navigating increasing clinical complexity while continuing to deliver high-quality\, patient-centered care. The session will highlight what is working today — and what needs to evolve — to support and strengthen community oncology as a foundational component of the cancer care ecosystem. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/endpoints-at-asco26/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/endpoints-at-asco26/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260527T100000
DTEND;TZID=America/Los_Angeles:20260527T123000
DTSTAMP:20260603T160737
CREATED:20260518T155257Z
LAST-MODIFIED:20260518T155257Z
UID:10001087-1779876000-1779885000@www.califesciences.org
SUMMARY:Plant Tour for Marketing & Creative Teams
DESCRIPTION:Tour the largest print facility in Southern California to learn how to automate some of your print marketing. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/dpi-plant-tour-for-marketing-creative-teams/
LOCATION:13257 Kirkham Way\, 13257 Kirkham Way\, Poway\, CA\, 92064\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260527T100000
DTEND;TZID=America/Los_Angeles:20260527T110000
DTSTAMP:20260603T160737
CREATED:20260504T184006Z
LAST-MODIFIED:20260504T184006Z
UID:10001077-1779876000-1779879600@www.califesciences.org
SUMMARY:Four Rituximabs\, One Name: A Biosimilar Deep-Dive
DESCRIPTION:Same skin. Different fruit. \nThat’s the position a biosimilar developer is in the day a regulator asks them to prove their molecule is “highly similar” to a reference product — because “highly similar” is a legal phrase that only means something if you have instruments sharp enough to see what different actually looks like. And for a monoclonal antibody\, different rarely shows up in the sequence. It shows up in the decorations. \nYoungseo Na and the Schwendeman Lab at the University of Michigan — in collaboration with MS Bioworks — just published a study that puts that idea on the bench. Biosimilar comparability is almost always done pairwise: one proposed biosimilar measured against its reference product\, one regulatory decision at a time. The Michigan team ran a different experiment. They took Rituxan and all three FDA-approved rituximab biosimilars — Truxima\, Ruxience\, and Riabni — three lots of each — and pushed every sample through three orthogonal Byos workflows on the same platform: native intact mass\, released glycan HILIC-FLR\, and LC-MS/MS peptide mapping. Three independent measurements of the same set of molecules\, cross-checked against each other. What came back reframes where biosimilar variation actually lives — and how characterization data should be shaped to see it. \nWhat you’ll learn in this webinar:\n\nWhere biosimilar variation actually lives.\nWhy the largest glycoform and afucosylation differences in this four-product set surfaced between biosimilars — not between biosimilar and reference — and what that means for the way comparability is usually reported.\nHow to build orthogonal confidence into a PTM characterization package.\nHow the Michigan team used three independent Byos workflows — intact MS\, released glycan\, and peptide mapping — with three independent quantification strategies\, so every finding could be corroborated module to module before it was called.\nHow glycan microheterogeneity maps onto ADCC potency.\nThe direct\, measurable relationship between total afucosylated glycan content and in-vitro ADCC activity across the four products — and why that link makes glycan profiling a load-bearing piece of any biosimilar characterization story.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/four-rituximabs-one-name-a-biosimilar-deep-dive/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/four-rituximabs-one-name-a-biosimilar-deep-dive/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260527T093000
DTEND;TZID=America/Los_Angeles:20260527T120000
DTSTAMP:20260603T160737
CREATED:20260407T201911Z
LAST-MODIFIED:20260407T201911Z
UID:10001057-1779874200-1779883200@www.califesciences.org
SUMMARY:Deciphering and re-engineering the immune response to cancer
DESCRIPTION:Event Agenda\n9:30 AM – Vendor Show/Guest Check-In \n10:30 AM – Vancouver-PBSS Welcome \n10:45 AM – Deciphering and re-engineering the immune response to cancer \n11:45 AM – Wrap-Up and Door Prizes \nSpeakers’ Bios\nBrad Nelson\, Ph.D. \nDistinguished Scientist\, \nScientific Director\, Immunotherapy Program\, \nBritish Columbia Cancer Research Institute \nVictoria BC\, Canada \nDr. Nelson is a native of Vancouver\, Canada. He received his B.Sc. from the University of British Columbia in 1987 and Ph.D. from the University of California at Berkeley in 1991. He completed postdoctoral training with Dr. Phil Greenberg and held faculty positions at the Fred Hutchinson Cancer Research Center and University of Washington in Seattle. In 2003\, he became the founding Director of BC Cancer’s Deeley Research Centre in Victoria BC. He is a Professor of Medical Genetics at the University of British Columbia and a Professor of Biochemistry/Microbiology at the University of Victoria. He holds the Lynda and Murray Farmer Immunotherapy Research Chair at BC Cancer and is a Fellow of the Royal Society of Canada. Dr. Nelson’s lab uses genomic and molecular approaches to study the immune response to cancer. As Scientific Director of BC Cancer’s Immunotherapy Program\, he is co-leading a phase I/II clinical trials program focused on engineered T cell therapies for lymphoid and gynecological cancers. Dr. Nelson is also a co-founder and CEO of Innovakine Therapeutics Inc\, which is using protein and cell engineering approaches to improve the efficacy and safety of cell-based therapies. He has played the guitar since he was a kid and is currently working his way (very slowly) through music of the Baroque era. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/deciphering-and-re-engineering-the-immune-response-to-cancer/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/deciphering-and-re-engineering-the-immune-response-to-cancer/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260521T160000
DTEND;TZID=America/Los_Angeles:20260521T190000
DTSTAMP:20260603T160737
CREATED:20260416T155943Z
LAST-MODIFIED:20260416T155943Z
UID:10001065-1779379200-1779390000@www.califesciences.org
SUMMARY:Beakers & Brews
DESCRIPTION:
URL:https://www.califesciences.org/event/beakers-brews-sd-may21/
LOCATION:CASA Campus Point\, 4242 Campus Point Ct\, San Diego\, CA\, 92121
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/04/Beakers-Brews-SD-Web-Card.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260521T160000
DTEND;TZID=America/Los_Angeles:20260521T180000
DTSTAMP:20260603T160737
CREATED:20260520T222642Z
LAST-MODIFIED:20260520T222642Z
UID:10001088-1779379200-1779386400@www.califesciences.org
SUMMARY:BioBeats Series - Lab to Lounge SSF
DESCRIPTION:Calling all scientists! Wind down your work day this Thursday for some tasty appetizers\, beer & wine\, and some good music with a live DJ. See the latest products and technologies from leading life science suppliers\, and hang out with your colleagues. No cost to attend. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/biobeats-series-lab-to-lounge-ssf/
LOCATION:Alexandria Cafe Bar & Lounge\, 201 Haskins Way\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260521T110000
DTEND;TZID=America/New_York:20260521T120000
DTSTAMP:20260603T160737
CREATED:20260430T202049Z
LAST-MODIFIED:20260430T202049Z
UID:10001075-1779361200-1779364800@www.califesciences.org
SUMMARY:How To Shine As Biotech Comes Back From the Brink
DESCRIPTION:Biotech has been pulling off some remarkable science of late\, while M&A and IPOs return to bolster the sector. But that doesn’t mean the industry is back from the brink. BioSpace will gather three early-stage biotech CEOs and members of the NextGen Class of 2026 to talk about surviving and thriving in this rollercoaster market\, all while bringing forward the next generation of medicines. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-shine-as-biotech-comes-back-from-the-brink/
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/how-to-shine-as-biotech-comes-back-from-the-brink/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260521T073000
DTEND;TZID=America/Los_Angeles:20260521T100000
DTSTAMP:20260603T160737
CREATED:20260506T220325Z
LAST-MODIFIED:20260506T220325Z
UID:10001082-1779348600-1779357600@www.califesciences.org
SUMMARY:Pharma Professionals Networking Event
DESCRIPTION:A casual networking event where you can grab a coffee and connect with others in the life sciences industry. Sponsored by Hyde Laboratory \n7:30-8:30 AM | Hiking at Paradise Falls. (Start at Mesa Trailhead) \n8:30-9:30 AM | Coffee and Breakfast at the Side Street Cafe after \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/pharma-professionals-networking-event/
LOCATION:Side Street Cafe\, 996 Lawrence Drive\, Thousand Oaks\, CA\, 91320\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260520T080000
DTEND;TZID=America/Los_Angeles:20260520T093000
DTSTAMP:20260603T160737
CREATED:20260506T220024Z
LAST-MODIFIED:20260506T220024Z
UID:10001081-1779264000-1779269400@www.califesciences.org
SUMMARY:Validation\, Engineering\, and QC Event for Pharma Professionals: San Diego
DESCRIPTION:Join us for a morning of coffee\, conversation\, and connections with leaders and peers across the life sciences sector. Whether you’re looking to expand your network\, share ideas\, or explore potential partnerships\, this is a great opportunity to engage with others shaping the future of the industry. \nDon’t miss this opportunity to connect with fellow life sciences professionals\, exchange insights\, and explore potential collaborations. We look forward to seeing you there! \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/validation-engineering-and-qc-event/
LOCATION:Karak House Coffee\, 9254 Scranton Rd\, San Diego\, CA\, 92121
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260519T100000
DTEND;TZID=America/Los_Angeles:20260519T110000
DTSTAMP:20260603T160737
CREATED:20260430T202417Z
LAST-MODIFIED:20260430T202417Z
UID:10001076-1779184800-1779188400@www.califesciences.org
SUMMARY:Advancing iPSC Therapies Toward Commercialization: Key Challenges and Acceleration Strategies
DESCRIPTION:Translating iPSC-based therapies from research to clinical application requires overcoming key challenges in scalable manufacturing\, including process efficiency\, product quality\, and regulatory compliance. This presentation explores practical strategies to improve iPSC expansion and differentiation\, with a focus on ECM proteins such as Laminin 521/511 and GMP-compliant systems that support robust\, scalable\, and automation-ready workflows. \nKey Highlights\n\nStrategies to enhance iPSC expansion and differentiation efficiency\nThe role of ECM proteins (Laminin 521/511) in maintaining cell stability and quality\nApproaches to ensure genetic stability\, pluripotency\, and high-purity cell populations\nFunctional validation of iPSC-derived cells (e.g.\, NK cells\, islet cells)\nKey considerations for GMP compliance\, safety control\, and scalable manufacturing\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advancing-ipsc-therapies-toward-commercialization/
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/advancing-ipsc-therapies-toward-commercialization/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260518
DTEND;VALUE=DATE:20260519
DTSTAMP:20260603T160737
CREATED:20260403T214343Z
LAST-MODIFIED:20260403T214343Z
UID:10001052-1779062400-1779148799@www.califesciences.org
SUMMARY:Healthy Lungs CA Advocacy Day
DESCRIPTION:Reducing the burden of lung cancer and COPD among at-risk and underserved communities. \nJoin colleagues from across the state to educate policymakers on efforts to improve lung health\, expand early detection and screenings\, and promote healthy environments. \nAdvocacy Day Program & Lunch\n9:30 AM – 1:00 PM \nPrelude Kitchen \n1117 11th Street\, Sacramento\, CA 95814 \nLegislative Meetings\n1:30 PM – 5:00 PM \nCapitol Annex Swing Space \n1021 O St.\, Sacramento\, CA 95814 \nReception\n5:00 PM – 6:30 PM \nPrelude Kitchen \n1117 11th Street\, Sacramento\, CA 95814 \nREGISTER» \nVIEW FLYER» \n 
URL:https://www.califesciences.org/event/healthy-lungs-ca-advocacy-day/
LOCATION:Sacramento\, CA\, Sacramento\, CA\, 95814\, United States
CATEGORIES:Advocacy & Government Relations,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260515T183000
DTEND;TZID=America/Los_Angeles:20260515T223000
DTSTAMP:20260603T160737
CREATED:20260330T161749Z
LAST-MODIFIED:20260512T213350Z
UID:10001048-1778869800-1778884200@www.califesciences.org
SUMMARY:Curebound Concert for Cures Featuring P!NK
DESCRIPTION:Since bursting onto the scene in 2000\, P!NK has built a career defined by fearless honesty\, extraordinary live shows\, and a refusal to fit a mold. Across nine studio albums and a greatest hits collection\, she’s sold over 60 million albums worldwide\, won three Grammy Awards (and 21 nominations)\, earned 15 Top 10 hits on the Billboard Hot 100 (including four #1’s)\, and a 2026 Rock & Roll Hall of Fame nominee. A trailblazer and passionate advocate for the cause she holds dear\, P!NK continues to evolve – staying true to herself and inspiring millions to do the same. \nDon’t miss an unforgettable night of P!NK’s full\, high-flying concert experience and be a part of this one-night-only event supporting lifesaving cancer research. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/curebound-concert-for-cures-2026/
LOCATION:Petco Park\, 100 Park Blvd\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260515T083000
DTEND;TZID=America/Los_Angeles:20260515T170000
DTSTAMP:20260603T160737
CREATED:20260327T183440Z
LAST-MODIFIED:20260327T183440Z
UID:10001045-1778833800-1778864400@www.califesciences.org
SUMMARY:Reimagining Science Education
DESCRIPTION:Science is evolving—is the way we train the next generation of experts keeping pace? 🧬📖 \nDigital Science\, Macmillan Learning\, Springer Nature\, and Scientific American are hosting a joint summit in San Francisco to tackle the evolution of the scientific workforce. This isn’t just a conversation for educators; it’s a vital touchpoint for industry leaders and innovators looking to influence the digital transformation of STEM. \n🗓️ May 15\, 2026 \n📍 SHACK15\, San Francisco 🌉 \n🔗 Register today: https://explore.macmillanlearning.com/reimagining-science-education-summit/ \nHosted by:
URL:https://www.califesciences.org/event/reimagining-science-education/
LOCATION:SHACK15\, Ferry Building\, 1\, Suite 201\, San Francisco\, CA\, 94111\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260514T080000
DTEND;TZID=America/Los_Angeles:20260514T173000
DTSTAMP:20260603T160737
CREATED:20260407T200853Z
LAST-MODIFIED:20260407T200853Z
UID:10001056-1778745600-1778779800@www.califesciences.org
SUMMARY:Small Molecule Preclinical Development and IND Filing: Nuts\, Bolts and Best Practices
DESCRIPTION:Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives\, expectations\, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often\, there are cases where too many nice-to-have studies crowd in the package but critical studies/issues are not addressed\, and this can lead to significant delays in clinical development. Additionally\, the regulatory environment is changing as rapidly as the industry. Therefore\, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety\, PK\, CMC\, and clinical plan is paramount. \nBelow are the topics to be covered: \n\n\n\nOverview of preclinical development and IND filing for small molecules\nKey preclinical studies required (Safety\, DMPK & CMC)\nClinical Development plans\n\n\n\n\nRegulatory strategie\nInteracting with regulatory agencies\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/small-molecule-preclinical-development-2/
LOCATION:Hilton San Diego/Del Mar\, 15575 Jimmy Durante Blvd\, Del Mar\, CA\, 92014\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260513T110000
DTEND;TZID=America/Los_Angeles:20260513T120000
DTSTAMP:20260603T160737
CREATED:20260407T202730Z
LAST-MODIFIED:20260407T202730Z
UID:10001058-1778670000-1778673600@www.califesciences.org
SUMMARY:Resolving Target Biology and Compound MOA at Scale: Enabling AI to Chat with Cells on the BioGPU Runtime
DESCRIPTION:Disease is driven by complex biological networks that remain only partially understood until experimentally resolved as a whole. \nTargets and compounds advance without clear biological understanding\, leading to failure. \nAI and large-scale experimental data have scaled hypotheses and insights. The bottleneck now shifts to biological resolution. \nStatic data\, including omics\, cannot capture cellular biology in action\, where pathways interact and drive disease. \nWithout experimental access to biology inside cells at AI scale and speed\, target biology and compound MOA remain only partially understood. \nA new paradigm brings cellular biology directly into AI: BioGPU\, the biology-resolution runtime for AI. Introducing visual computing — a high-content\, pathway-level imaging experimental modality in cells at scale\, capturing biology in action. \nThis generates disease biology models of pathway and network activity in real cells. \nThrough the BioGPU agent\, AI models chat with cells\, operating on these models at runtime in a continuous loop of hypothesis\, experiments\, and refinement to: \n\nResolve target biology — what targets do and how they are regulated\, enabling causal targets to advance and weak targets to be killed\nResolve compound MOA\, how compounds modulate the system\, including pathway and off-target effects\n\nYou will see this in rheumatoid arthritis and ALS case studies\, where BioGPU connects to frontier AI systems\, ChatGPT and Gemini AI co-scientists\, operating on the BioGPU models at runtime to test and refine hypotheses\, deprioritize inactive pathways\, surface novel mechanisms and high-confidence targets. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resolving-target-biology-and-compound-moa-at-scale/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/resolving-target-biology-and-compound-moa-at-scale/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260512T170000
DTEND;TZID=America/Los_Angeles:20260512T190000
DTSTAMP:20260603T160737
CREATED:20251110T193712Z
LAST-MODIFIED:20260410T200620Z
UID:10000939-1778605200-1778612400@www.califesciences.org
SUMMARY:Spring Reception
DESCRIPTION:Come together with us in the nation’s capital for our annual Spring Reception\, where we welcome Members of Congress\, their staff\, CLS members\, and life science executives for a networking reception ahead of our day of advocacy on Capitol Hill. This reception is free and all are welcome to attend. \nREGISTER» \nThis event has been designed to comply with House and Senate Ethics rules for widely attended events under House Rule 25\, clause 5(a)(4)(A) and Senate Rule 35.1(d)(1). Members and staff who have questions should contact their respective Ethics Committee. \nSPONSORSHIP OPPORTUNITIES\nIndustry Champion – $8\,000\nAcademic & Non-Profit – $5\,000\nExclusively for CLS Board Member Companies \n◆ Your sponsorship directly funds participation for one early-stage life science company in the CLS Hill Day Fly-In\, giving emerging innovators a seat at the table with policymakers\n◆ Recognition as a champion of the next generation of life sciences innovation\, acknowledged in Hill Day materials and CLS communications\n◆ Prominent recognition in outreach campaign to congressional offices\n◆ Prominent logo recognition on all Spring Reception marketing and promotional materials\n◆ Logo included in post-event recap email sent to all attendees and CLS membership \nSupporting Sponsor – $3\,000\nNon-Member – $5\,000\nAcademic & Non-Profit – $1\,000\n◆ Recognition in outreach campaign to congressional offices\n◆ Logo recognition on all event marketing and promotional materials\n◆ Logo included in post-event recap email sent to all attendees and CLS membership \n \nContact sponsorship@califesciences.org for more information about sponsorships.
URL:https://www.califesciences.org/event/spring-reception-2026/
CATEGORIES:Advocacy & Government Relations,California Life Sciences,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/05.12-Spring-Reception.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260512T160000
DTEND;TZID=America/Los_Angeles:20260512T180000
DTSTAMP:20260603T160737
CREATED:20260506T215731Z
LAST-MODIFIED:20260506T215731Z
UID:10001080-1778601600-1778608800@www.califesciences.org
SUMMARY:2026 U.S.-Japan Healthcare Connection Reverse Pitch Event
DESCRIPTION:Come hear pitches from leading Japan-focused strategic investors and pharmaceutical companies including AN Ventures\, Astellas\, Chugai Pharmaceuticals\, Daiichi Sankyo\, Nippon Life\, Ono Pharmaceuticals and Recor Medical. Our presenters will share their investment and partnering priorities with the audience\, and tell you how to connect with them to discuss strategic partnering opportunities. \nThis is an amazing opportunity to get in front of leading US biotech\, pharma and life science strategic partners and investors that are that are interested in startup life science firms. In addition\, we will have a panel discussion featuring market-entry experts from the life sciences industry who will share their thoughts on the topic “Why do therapeutics in Japan?” \nThis Biopharma-focused event is our sixth Reverse Pitch event – following on the heels of our successful Medtech and Diagnostics Reverse Pitch event in November 2025. The event will be followed by a networking reception where you will have the opportunity to connect with the presenters and others with deep experience in the Japanese market. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/2026-us-japan-healthcare-connection-reverse-pitch-event/
LOCATION:Triple Ring Technologies\, 39655 Eureka Dr\, Newark\, CA\, 94560\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260512T100000
DTEND;TZID=America/Los_Angeles:20260512T110000
DTSTAMP:20260603T160737
CREATED:20260430T201733Z
LAST-MODIFIED:20260430T201733Z
UID:10001074-1778580000-1778583600@www.califesciences.org
SUMMARY:Cell-Based Platforms Driving the Next Wave of Drug Development
DESCRIPTION:As drug discovery evolves\, screening efficiency is critical to R&D success. Traditional methods often fall short when addressing complex targets and high-throughput demands. Functional cell lines offer a scalable solution with standardized design\, precise engineering\, and consistent performance—enabling faster and more accurate drug screening. \nIn this webinar\, we’ll explore how cell-based platforms are transforming early-stage drug development. With a focus on functional cell lines\, the session will highlight how these systems support efficient target validation and high-throughput screening—helping researchers accelerate the path from discovery to candidate selection. \nKey Highlights:\n\nHow functional cell lines enhance screening efficiency and reliability\nKey applications in target validation and drug screening\nInsights into cell model selection and assay development\nStrategies to streamline workflows and accelerate R&D\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/cell-based-platforms-driving-the-next-wave-of-drug-development/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/cell-based-platforms-driving-the-next-wave-of-drug-development/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260511T084500
DTEND;TZID=America/Los_Angeles:20260511T173000
DTSTAMP:20260603T160737
CREATED:20260316T151719Z
LAST-MODIFIED:20260316T151719Z
UID:10001043-1778489100-1778520600@www.califesciences.org
SUMMARY:Formulation Development of Proteins and Antibodies: Fundamentals of Liquid Formulation\, High-Dose Delivery\, Non-Aqueous Formulations\, and GI Delivery
DESCRIPTION:Developing biopharmaceutical formulations that offer maximum patient convenience without sacrificing safety and efficacy for entities such as mAbs\, antibody drug conjugates\, and Fc-conjugates among others is increasingly complex.. Many drugs now require doses for subcutaneous delivery beyond what can be achieved with a 1 mL injection of an aqueous formulation. A significant hurdle in meeting this need is achieving the high drug concentrations required for these doses. \nThis workshop is structured to first provide an overview of pharmaceutical development. It will then showcase successful strategies across various areas\, including developability assessments\, surfactant use\, achieving high-dose delivery via non-aqueous suspensions\, and enabling the gastrointestinal delivery of biopharmaceuticals. The event will conclude with a discussion focusing on intellectual property within the drug product development landscape. \nThe workshop will cover the following key areas in pharmaceutical development of biopharmaceuticals: \n\nStrategies for Success: Successful approaches for molecule design\, developability assessments\, formulation design and minimizing surfactant degradation will be detailed.\nNew Technologies: An overview of novel technologies enabling high concentration\, high dose\, and gastrointestinal delivery.\nIntellectual Property: A summary of the intellectual property landscape relevant to biopharmaceutical drug product development.\n\nKey Topics\n\nAntibody engineering\nPharmaceutical development roadmap\nSurfactant selection and degradation mitigation\nDevelopability assessment for high concentration biologics\nHigh concentration antibody landscape\nNovel strategies for achieving ultra high concentrations through non-aqueous suspensions\nGastrointestinal delivery of biologics\nIntellectual property landscape for biologics drug product development\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/formulation-development-of-proteins-and-antibodies/
LOCATION:Kilroy Oyster Point\, 357 Oyster Point Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260508T113000
DTEND;TZID=America/Los_Angeles:20260508T133000
DTSTAMP:20260603T160737
CREATED:20260407T200002Z
LAST-MODIFIED:20260407T200002Z
UID:10001054-1778239800-1778247000@www.califesciences.org
SUMMARY:Highlights of 2025 FDA Drug Approvals
DESCRIPTION:In this presentation\, the speakers will summarize the 2025 cohort of new drugs approved by the FDA. Statistics on the overall cohort will be discussed\, followed by a short summary of key features of approved drugs. The speakers will also highlight case studies with interesting discovery and development stories. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/highlights-of-2025-fda-drug-approvals/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/highlights-of-2025-fda-drug-approvals/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260507T180000
DTEND;TZID=America/Los_Angeles:20260507T223000
DTSTAMP:20260603T160737
CREATED:20260303T204206Z
LAST-MODIFIED:20260303T204206Z
UID:10001031-1778176800-1778193000@www.califesciences.org
SUMMARY:Battle of the Bio/Tech Bands
DESCRIPTION:The Battle of the BioTech Bands is heading West! After an incredible run in Boston—including our milestone 10th anniversary this May and over $1.5 million raised since inception—we’re excited to grow even bigger. We’re expanding our reach with a brand-new West Coast battle. \nREGISTER» \nHosted by: \n \n 
URL:https://www.califesciences.org/event/battle-of-the-bio-tech-bands-2026/
LOCATION:Belly Up Tavern\, 143 S Cedros Ave\, Solona Beach\, CA\, 92075
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260507T160000
DTEND;TZID=America/Los_Angeles:20260507T190000
DTSTAMP:20260603T160737
CREATED:20260416T155202Z
LAST-MODIFIED:20260416T155820Z
UID:10001064-1778169600-1778180400@www.califesciences.org
SUMMARY:Beakers & Brews
DESCRIPTION:
URL:https://www.califesciences.org/event/beakers-brews-ssf-may7/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/04/Beakers-Brews-SF-Web-Card-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260506T190000
DTEND;TZID=America/Los_Angeles:20260506T210000
DTSTAMP:20260603T160737
CREATED:20260422T183703Z
LAST-MODIFIED:20260422T183703Z
UID:10001071-1778094000-1778101200@www.califesciences.org
SUMMARY:AI x Drug Discovery | SynBioBeta Mixer
DESCRIPTION:Exclusive mixer following the SynBioBeta main stage — an evening built for the vanguard of the TechBio ecosystem.\nIf you’re a founder\, investor\, or pharma partner working at the intersection of AI and biology\, come go beyond the panel and into deeper conversations on: \n→ Intelligent molecules \n→ Sequence design \n→ Programmable therapeutics \nYou’ll be in the room with SynBioBeta panelists\, active VCs\, biotech engineers\, research scientists\, and startup founders — in an elevated\, relaxed setting built for meaningful connection\, not name-tag small talk. \n🤝 Proudly partnering with SynBioBeta — friends of our AI x biotech community get an exclusive discount pass to the summit: https://www.syntheticbiologysummit.com/tickets/magnet \nCo-hosted with my partners Charleston Wong\, Vincent Song\, and Mickey Makhija\, alongside our organizing communities: \n\nMagnet Ventures — AI-driven biotech investment\, focused on computational drug discovery and therapeutic delivery\nTech Brews — 2\,000+ global founders & innovators across healthtech\, biotech\, and life sciences\nTechBio Transformers — scientists\, PMs\, computational biologists\, and engineers working at the biology x software x AI frontier\n\nHuge thanks to our sponsors: \n\nCornucopia Bio — infrastructure for self-driving labs\nMorrison Foerster (MoFo) — global life sciences & tech law firm\nSingapore Global Network — a 220k+ global professional community\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/ai-x-drug-discovery-synbiobeta-mixer/
LOCATION:Selva\, 44 S Almaden Ave\, San Jose\, CA\, 95113\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260506T110000
DTEND;TZID=America/Los_Angeles:20260506T140000
DTSTAMP:20260603T160737
CREATED:20260504T184327Z
LAST-MODIFIED:20260504T184327Z
UID:10001078-1778065200-1778076000@www.califesciences.org
SUMMARY:Science & Tech Expo @ The Cove\, SSF
DESCRIPTION:Attend one of the most popular events at The Cove in South San Francisco on Wednesday. \nSee the latest life science products\, technologies and services from over 40 leading industry suppliers\, and network with professionals in our industry while enjoying food and refreshments\, giveaways and raffle prizes. No cost to attend. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/science-tech-expo-the-cove-ssf/
LOCATION:AC Hotel San Francisco Airport/ Oyster Point Waterfront\, 1333 Veterans Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260506T110000
DTEND;TZID=America/Los_Angeles:20260506T120000
DTSTAMP:20260603T160737
CREATED:20260407T202955Z
LAST-MODIFIED:20260407T202955Z
UID:10001059-1778065200-1778068800@www.califesciences.org
SUMMARY:The Foundation for Trustworthy AI: The FAIR Data Playbook for Pharma
DESCRIPTION:Is your AI trustworthy? 🤖🔬 \nA ‘scientific content crisis’ is leaving 27% of life science professionals unable to trace the data powering their AI. This isn’t just a technical hurdle—it’s a regulatory risk. \nJoin our upcoming webinar with Fierce Pharma “The Foundation for Trustworthy AI: The FAIR Data Playbook for Pharma\,” to learn how to move from aspiration to full implementation. \nWe’ll dive into:\n✅ The Governance Gap: Moving to a traceable\, audit-ready data pedigree.\n✅ Knowledge Graphs: Creating the infrastructure to make internal data AI-ready.\n✅ Grounded AI: Using neuro-symbolic approaches to eliminate LLM hallucinations. \n📅 Date: Wednesday\, May 6\, 2026 | 🕚 Time: 11:00 AM ET \nDon’t let your AI projects stall at the pilot stage. Register now to build a foundation of verified evidence \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-foundation-for-trustworthy-ai-the-fair-data-playbook-for-pharma/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/the-foundation-for-trustworthy-ai-the-fair-data-playbook-for-pharma/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260505T110000
DTEND;TZID=America/Los_Angeles:20260505T140000
DTSTAMP:20260603T160737
CREATED:20260316T151403Z
LAST-MODIFIED:20260316T151403Z
UID:10001042-1777978800-1777989600@www.califesciences.org
SUMMARY:R&D Vendor Discovery Day - San Diego
DESCRIPTION:Join Scientist.com on May 5th for our annual San Diego Vendor Discovery Day! Discover novel technologies\, network with industry professionals\, and enjoy a complimentary lunch with fellow San Diego-based biopharma professionals. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/rd-vendor-discovery-day-san-diego/
LOCATION:Farmer & The Seahorse\, 10996 Torreyana Rd Ste 240\, San Diego\,\, CA\, 92121\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260508
DTSTAMP:20260603T160737
CREATED:20260319T202656Z
LAST-MODIFIED:20260319T202656Z
UID:10001044-1777852800-1778198399@www.califesciences.org
SUMMARY:SynBioBeta 2026: The Global Synthetic Biology Partnering Summit
DESCRIPTION:Every May for the past 14 years\, more than 2\,000 investors\, Fortune 500 executives\, founders\, and scientists have gathered at SynBioBeta to make deals\, start partnerships\, and shape what the next 6–12 months of the life sciences ecosystem will look like. \nThis year’s program spans 6 frontier areas shaping the future of biology: \nAI × Biology\nFoundation models\, multimodal biological AI\, predictive design for drugs\, materials\, and sustainable systems. \nHuman Health & Longevity\nAI-powered drug discovery\, cell and gene therapies\, diagnostics\, and engineered therapeutics. \nPlanetary Health & Sustainability\nFood and agriculture\, climate tech\, sustainable materials\, and bio-enabled manufacturing. \nBiomanufacturing at Scale\nContinuous fermentation\, scalable bioprocessing\, and real-time monitoring for cost-competitive production. \nTools\, Tech & Platforms\nSequencing\, synthesis\, genome editing\, automation\, cloud labs\, and AI-driven discovery platforms. \nThe Business of Biology\nCommercialization\, market strategy\, funding\, partnerships\, regulatory\, and IP strategy. \nThe stage will feature leaders such as David Sinclair\, Pardis Sabeti\, Drew Endy\, and Emily Leproust\, alongside executives and research leaders from organizations including: \nDARPA • ARPA-H • U.S. Department of Energy \nIndustry leaders including: \nProcter & Gamble • Unilever • Mars \nAnd global biopharma companies including: \nAstraZeneca • GlaxoSmithKline • Novo Nordisk • Eli Lilly \n\nCLS members receive a 10% discount to attend the full conference. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nHosted by:
URL:https://www.califesciences.org/event/synbiobeta-2026/
LOCATION:150 West San Carlos Street\, 150 West San Carlos Street\, San Jose\, CA\, 95113\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T160000
DTEND;TZID=America/Los_Angeles:20260430T180000
DTSTAMP:20260603T160737
CREATED:20260427T202211Z
LAST-MODIFIED:20260427T202211Z
UID:10001073-1777564800-1777572000@www.califesciences.org
SUMMARY:BioBeats
DESCRIPTION:Science first.  Social next.\nMove from Lab to Lounge over delicious appetizers\, beer and wine at the next installment of the BioBeats Series\, which brings the life science community together over live music and relaxed conversations.  See the latest products from leading suppliers\, and network with colleagues.  No cost to attend this community event.\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bioev-biobeats/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T084500
DTEND;TZID=America/Los_Angeles:20260430T173000
DTSTAMP:20260603T160737
CREATED:20260401T221727Z
LAST-MODIFIED:20260401T221727Z
UID:10001051-1777538700-1777570200@www.califesciences.org
SUMMARY:Vendor Scientific Highlights Symposium: DMPK & Bioanalytical Technologies and Case Studies
DESCRIPTION:This symposium will highlight emerging strategies and practical considerations in drug metabolism\, bioanalysis\, and translational sciences for novel therapeutic modalities. As the industry moves beyond traditional small molecules toward increasingly complex platforms — including oligonucleotides\, peptides\, and antibody–drug conjugates (ADCs) — there is a growing need for fit-for-purpose ADME characterization and advanced analytical approaches. \nExpert speakers from industry will share real-world case studies and methodological advances addressing in vitro ADME characterization and innovative LC–MS bioanalytical strategies across a range of therapeutic modalities. Topics will include modality-specific challenges\, comparison of novel modalities with small molecules\, and lessons learned from both cleavable and non-cleavable ADC linker systems. \nThis event will provide valuable insights for scientists working in DMPK\, bioanalysis\, and translational research\, offering practical perspectives on how evolving analytical technologies are being applied to support drug discovery and development in a rapidly changing therapeutic landscape. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/vendor-scientific-highlights-symposium/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T160000
DTEND;TZID=America/Los_Angeles:20260429T190000
DTSTAMP:20260603T160737
CREATED:20260427T161055Z
LAST-MODIFIED:20260427T161055Z
UID:10001072-1777478400-1777489200@www.califesciences.org
SUMMARY:Strategic R&D Partner Seminar
DESCRIPTION:PROGRAM HIGHLIGHTS\n\n4:00 PM Registration & Welcome\n4:20 PM Talk session\n\nAutomated Platform for Pharmaceutical Formulation Development\n\nKenan Pandza\, VP of R&D — Persist AI\n\n\nOne Vision\, Two Strategies: Integrated & Open-Platform Lab Automation\n\nAndy Sasaki\, GM R&D Center — Shimadzu Scientific Instruments\n\n\nFind the Needle in the Haystack with FAST Fluorescence Imaging\n\nJoerg Martini\, Assoc. Director — SRI International\n\n\nAI-Driven Culture Media Optimization for Biopharmaceuticals\n\nHirotaka Kuroda\, Senior Researcher — Shimadzu Corporation\n\n\n\n\n6:00 PM Networking & Poster Session\n\nPAT\, NAMs\, Particle Separation & more\n\n\n\nKEY TOPICS\nLab Automation • HPLC & LCMS & Analytics • Cell Culture AI • Fluorescence Imaging • Drug Formulation • PAT • Particle Separation • NAMs • Centrifugal Field-flow Fractionation • Pharma R&D \nIdeal for pharmaceutical scientists\, analytical chemists\, bioprocess engineers\, and life science researchers \nREGISTER»
URL:https://www.califesciences.org/event/strategic-rd-partner-seminar/
LOCATION:The Forum\, 750 Gateway Blvd\, South San Francisco\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
END:VCALENDAR